Page 92 - Programme book for The International Liver Congress 2015, EASL ILC 2015

FRIDAY, APRIL 24, 2015

Parallel Session: Liver Tumours: Clinical Lehar 1 & 2

Chairs:
Helen Reeves, The United Kingdom
Wolfgang Sieghart, Austria

SCIENTIFIC PROGRAMME ABSTRACT FIRST SELECTIVE SMALL MOLECULE INHIBITOR OF
O048 FGFR4 FOR THE TREATMENT OF HEPATOCELLULAR
16:00 - 16:15 CARCINOMAS WITH AN ACTIVATED FGFR4 SIGNALING
PATHWAY
ABSTRACT Klaus Hoeflich, The United States
O049
16:15 - 16:30 SERUM LIPIDOMIC PROFILING FOR SCREENING
POTENTIAL BIOMARKERS OF HEPATOCELLULAR
ABSTRACT CARCINOMA BY ULTRAPERFORMANCE LIQUID
O050 CHROMATOGRAPHY–MASS SPECTROMETRY
16:30 - 16:45 Ana Maria Passos-Castilho, Brazil

ABSTRACT A NEW ALGORITHM FOR PREDICTING THE
O051 HEPATOCELLULAR CARCINOMA OCCURRENCE IN
16:45 - 17:00 CIRRHOTIC PATIENTS
Simona Bota, Austria
ABSTRACT
O052 SOX9 IS A NOVEL CANCER STEM CELL MARKER
17:00 - 17:15 SURROGATED BY OSTEOPONTIN IN HUMAN
ABSTRACT HEPATOCELLULAR CARCINOMA
O053 Takayuki Kawai, Japan
17:15 - 17:30
ASSESSMENT OF THE HONG KONG LIVER CANCER
STAGING SYSTEM IN EUROPE
Philippe Kolly, Switzerland

GALNT14 GENOTYPE INDEPENDENTLY PREDICTS
COMPLETE THERAPEUTIC RESPONSES OF
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR
CARCINOMA
Chau-Ting Yeh, Taiwan

92 The International Liver Congress™ 2015 • ILC Programme